common.study.topics.clinical

DuraDerm® for the Reduction of Pin Track Infection

common.study.values.description

DuraDerm® for the Reduction of Pin Track Infection

The purpose of the study is to investigate additional clinical uses for DuraDermAR. DuraDermAR is a FDA approved, 510k, medical device, but has not been approved for use on patients with pin track sites as a way to lower the infection rate and is investigational for this purpose. The approved uses include wound care and post-operative care. About 20 subjects will take part in this study.

common.study.values.location

participant.ui.study.affiliations-map.online-study.header-virtual

participant.ui.study.affiliations-map.online-study.text

participant.ui.study.affiliations-map.legend.locations participant.ui.study.affiliations-map.legend.selected

common.study.values.methods

No pharmaceutical medication involved common.study.methods.has-drugs-no
Patients and healthy individuals accepted common.study.methods.is-healthy-no

Device - DuraDerm

DuraDerm® is a 510K FDA cleared medical device indicated for providing a covering over minor wounds and scrapes that are clean and dry. The microbicidal liquid solution consists of organic polymers . The unique formulation eradicates any organisms (bacteria, fungi, viruses) it comes in contact with. This is a result of the solvent's activity against an infinite number of organisms After eradication is complete, the solvent then transitions into a clear, elastomeric, non-odorous film for coverin ...read more on ClinicalTrials.org

participant.views.study.view.additional

participant.views.study.view.scientific-title

An Evaluation of the Use of DuraDerm® for the Reduction of Pin Track Infection in Research Participants Receiving External Fixation Following Deformity Correction and Traumatic Provisional Fixation

common.study.values.clinical-trial-id

NCT03756506

participant.views.study.view.id

bo2Aza